SHOP APOTHEKE EUROPE NVSHOP APOTHEKE EUROPE NVSHOP APOTHEKE EUROPE NV

SHOP APOTHEKE EUROPE NV

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.74 B‬EUR
‪−12.04 M‬EUR
‪1.80 B‬EUR
‪13.27 M‬
Beta (1Y)
0.11

About REDCARE PHARMACY N.V.

CEO
Olaf Heinrich
Headquarters
Sevenum
Employees (FY)
‪2.08 K‬
Founded
2001
ISIN
NL0012044747
FIGI
BBG00KTP50K0
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SHOP is 128.4 EUR — it has decreased by 4.61% in the past 24 hours. Watch SHOP APOTHEKE EUROPE NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange SHOP APOTHEKE EUROPE NV stocks are traded under the ticker SHOP.
SHOP APOTHEKE EUROPE NV is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
SHOP stock is 4.83% volatile and has beta coefficient of 0.11. Track SHOP APOTHEKE EUROPE NV stock price on the chart and check out the list of the most volatile stocks — is SHOP APOTHEKE EUROPE NV there?
Yes, you can track SHOP APOTHEKE EUROPE NV financials in yearly and quarterly reports right on TradingView.
SHOP stock has risen by 0.00% compared to the previous week, the month change is a 14.11% fall, over the last year SHOP APOTHEKE EUROPE NV has showed a 43.24% increase.
SHOP net income for the last quarter is ‪−7.81 M‬ EUR, while the quarter before that showed ‪−5.58 M‬ EUR of net income which accounts for −39.85% change. Track more SHOP APOTHEKE EUROPE NV financial stats to get the full picture.
Today SHOP APOTHEKE EUROPE NV has the market capitalization of ‪2.70 B‬, it has increased by 0.47% over the last week.
No, SHOP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SHOP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHOP APOTHEKE EUROPE NV stock right from TradingView charts — choose your broker and connect to your account.
SHOP reached its all-time high on Feb 15, 2021 with the price of 246.5 EUR, and its all-time low was 28.5 EUR and was reached on Aug 15, 2019. View more price dynamics on SHOP chart.
See other stocks reaching their highest and lowest prices.
As of May 9, 2024, the company has ‪2.08 K‬ employees. See our rating of the largest employees — is SHOP APOTHEKE EUROPE NV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHOP APOTHEKE EUROPE NV technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHOP APOTHEKE EUROPE NV stock shows the buy signal. See more of SHOP APOTHEKE EUROPE NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHOP APOTHEKE EUROPE NV future price: according to them, SHOP price has a max estimate of 190.00 EUR and a min estimate of 109.00 EUR. Watch SHOP chart and read a more detailed SHOP APOTHEKE EUROPE NV stock forecast: see what analysts think of SHOP APOTHEKE EUROPE NV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHOP APOTHEKE EUROPE NV EBITDA is ‪94.40 M‬ EUR, and current EBITDA margin is 2.25%. See more stats in SHOP APOTHEKE EUROPE NV financial statements.